Telomere-related gene risk model predicts prognostic and immune microenvironment alterations in prostate cancer

Sci Rep. 2025 Apr 25;15(1):14536. doi: 10.1038/s41598-025-98663-z.

Abstract

The improvement of the prediction of prostate cancer (PCa) is a major challenge in disease management. This study analysed a total of 147,856 cells and identified 15 distinct cell types using single-cell RNA-sequencing (scRNA-seq) and bulk RNA-seq data from TCGA and GEO databases. Of these cells, 31,256 exhibited a high telomere-related gene score and were predominantly composed of myeloid dendritic cells (mDCs). Simultaneously, pseudo-temporal analysis indicated that mDCs are in the later stages of the differentiation trajectory, suggesting the significant role of mDCs as telomere-active cells in the development of PCa. Analysis of cell-cell communication revealed significant differences, particularly an increase in communication between mDCs and CTLs, alongside a decrease in communication between mDCs and B cells. These variations may represent critical nodes influencing the development of PCa. Additionally, two hub genes were utilized to create risk models, with ROC curves confirming their predictive efficacy for 3-, 5-, and 10-year survival rates in patients. Functional analysis of these genes was conducted, and NPY siRNA transfection notably inhibited proliferation in LNCaP and DU145 cells. Furthermore, the models demonstrated that high-risk patients had poorer overall survival, greater immune infiltration, and reduced sensitivity to chemotherapeutic drugs.

Keywords: Prostate cancer; Risk mode; Single-cell RNA-sequencing; Telomere-related gene; Tumour immune environment.

MeSH terms

  • Biomarkers, Tumor / genetics
  • Cell Line, Tumor
  • Dendritic Cells / immunology
  • Dendritic Cells / metabolism
  • Gene Expression Regulation, Neoplastic
  • Humans
  • Male
  • Prognosis
  • Prostatic Neoplasms* / genetics
  • Prostatic Neoplasms* / immunology
  • Prostatic Neoplasms* / mortality
  • Prostatic Neoplasms* / pathology
  • Telomere* / genetics
  • Tumor Microenvironment* / genetics
  • Tumor Microenvironment* / immunology

Substances

  • Biomarkers, Tumor